XML 52 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ (Deficit) Equity (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Fair Value of Options Granted Black-Scholes-Merton Model

The assumptions used to determine the fair value of options granted in the three months ended March 31, 2025 using the Black-Scholes-Merton model are as follows:

 

Dividend yield  -%
Risk-free interest rate  3.62 to 4.23%
Expected volatility (weighted-average and range, if applicable)   100%
Expected term   6 to 6.5 years 
Schedule of Stock Option and Related Information

A summary of the Company’s stock option activities and related information for the three months ended March 31, 2025 is as follows:

 

Stock Option  No. of Stock
Option
  

Weighted-Average

Grant Date

Fair Value Per

Stock Option

   Weighted-Average
Remaining
Contractual Life
(in Years)
 
January 1, 2025   105,090   $98.55    0.65 
Granted   127,153    3.40    

1.26

 
Exercised   -    -    - 
Expired   -    -    - 
Cancelled / Forfeited   (20,731)   (69.07)   - 
March 31, 2025   211,512   $44.24    0.93 

 

 

A summary of the Company’s stock option activities and related information for the year ended December 31, 2024 is as follows:

 

Stock Option  No. of Stock
Option
  

Weighted-Average

Grant Date

Fair Value Per

Stock Option

   Weighted-Average
Remaining
Contractual Life
(in Years)
 
January 1, 2024   114,301   $108.62    1.65 
Granted   -    -    - 
Exercised   -    -      
Expired   -    -    - 
Cancelled / Forfeited   (9,211)   (76.60)   - 
December 31, 2024   105,090   $98.55    0.65 
Schedule of Options Outstanding

The following options were outstanding at their respective exercise price:

 

Exercise price options outstanding  March 31, 2025   December 31, 2024 
$8.00   45,757    - 
$9.68   81,396    - 
$31.20   15,034    18,265 
$51.60   17,500    17,500 
$80.00   6,825    6,825 
$133.40   45,000    62,500 
Total   211,512    105,090 
Schedule of Restricted Stock Units

A summary of the Company’s RSU activities and related information for the three months ended March 31, 2025 is as follows:

 

Restricted Stock Units  No. of RSU  

Weighted-Average

Grant Date

Fair Value
Per RSU

   Weighted-Average
Remaining
Contractual Life
(in Years)
 
January 1, 2025   8,583   $26.20    1.00 
Granted   -    -    - 
Vested   (4,292)   26.20    - 
Expired   -    -      
Cancelled / Forfeited   (980)   -    - 
March 31, 2025   3,311   $26.20    0.75 

 

 

A summary of the Company’s RSU activities and related information for the year ended December 31, 2024 is as follows:

 

Restricted Stock Units  No. of RSU  

Weighted-Average

Grant Date

Fair Value
Per RSU

   Weighted-Average
Remaining
Contractual Life
(in Years)
 
January 1, 2024   16,175   $26.20    2.00 
Granted   -    -    - 
Vested   (5,392)   26.20    - 
Expired   -    -      
Cancelled / Forfeited   (2,200)   26.20    - 
December 31, 2024   8,583   $26.20    1.00 
Schedule of Exercise Price of Restricted Stock Units

The following RSU were outstanding at their respective vest price:

 

Vest price RSU outstanding  March 31, 2025   December 31, 2024 
$26.20   3,311    8,583 
Total   3,311    8,583